About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles announces quality Purified Exosomes to support research in drug delivery.

(PRUnderground) July 2nd, 2025

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the availability of its quality Purified Exosomes to support research in drug delivery, regenerative medicine, and various therapeutic applications.

Exosomes are extracellular vesicles secreted by human cells that exhibit biofilm characteristics. They have a particle size of 30-150 nanometers. All relevant cells in the body secrete exosomes of the corresponding cell type. These extracellular vesicles have a phospholipid bilayer structure and can carry important biological information, such as proteins, nucleic acids (e.g., microRNA and long non-coding RNA), and lipids. These extracellular vesicles, composed of cell membranes, can attach to target cells through surface adhesion proteins and carrier ligands, such as tetrapeptides, integrins, CD11b, and CD18 receptors, and deliver their payloads. Several studies have shown that, depending on their properties and origin, extracellular vesicles, such as exosomes, have specific cell tropism and can be used to target diseased tissues or organs.

Exosomes are derived from endosomes. These membranous vesicles are released outside the cell by fusing with the plasma membrane via a multivesicular body (MVB). They contain a variety of biomolecules, including proteins, nucleic acids, and phospholipids. Exosomes have many biological functions and serve as an important pathway for the intercellular exchange of substances and signals. Exosomes play a corresponding role in the development of many known diseases and participate in various physiological and pathological processes.

Exosome carriers offer the benefits of both cellular drug delivery and nanotechnology. As a new type of drug delivery carrier with natural properties, they can cross the biological barriers of the human body. Therefore, using exosomes as carriers enables effective and safe drug delivery. They can be delivered to all major systems of the human body, making them a viable and effective method of treating diseases with a promising future.

Exosomes derived from animal, plant, and microbial sources exhibit certain biological activities, such as anti-inflammatory, antioxidant, whitening, and anticancer properties. They can be used in the research of functional foods, nutraceuticals, cosmetics, and cancer therapies. CD Bioparticles produces and supplies high-purity exosomes from animal, plant, and microbial sources, including the Exosomes from MCF-7 (CDE23-001), Exosomes from MDA-MB-231 (CDE23-002), and Exosomes from PCS-500-011 (CDE23-008). For instance, the Exosomes from HEK293 Cells (CDE23-015) are frozen exosomes (>1×10^6) from the HEK293 human embryonic kidney cell line. They can be used as an exosome standard in the evaluation of biomarkers.

CD Bioparticles is proud to provide a comprehensive range of high-purity exosomes, ensuring researchers have access to the highest quality materials for their critical work. To learn more about solutions for exosome research, please visit https://www.cd-bioparticles.net/purified-exosomes.

About CD Bioparticles

CD Bioparticles specializes in manufacturing and supplying nanoparticles, microparticles, and coatings for diagnostics and research, alongside developing customized, biocompatible drug delivery systems. We offer diverse formulation technologies (from liposomes to polymer nanoparticles) and comprehensive services, including surface functionalization, antibody immobilization, and contract research for drug delivery.

The post CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research first appeared on

Press Contact

Name: Richard J. Gray
Phone: 1-631-346-0027
Email: Contact Us

Original Press Release.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.